|
[1]
|
Evaluation of epigenetic methylation biomarkers for the detection of colorectal cancer using droplet digital PCR
Scientific Reports,
2023
DOI:10.1038/s41598-023-35631-5
|
|
|
|
|
[2]
|
Evaluation of a Multi-Gene Methylation Blood-Test for the Detection of Colorectal Cancer
Medical Sciences,
2023
DOI:10.3390/medsci11030060
|
|
|
|
|
[3]
|
Glycoproteomics-based liquid biopsy: translational outlook for colorectal cancer clinical management in Southeast Asia
Future Oncology,
2023
DOI:10.2217/fon-2023-0704
|
|
|
|
|
[4]
|
Future of Colorectal Cancer Screening: From One-Size-FITs-All to Tailor-Made
Frontiers in Gastroenterology,
2022
DOI:10.3389/fgstr.2022.906052
|
|
|
|
|
[5]
|
Accuracy of blood-based biomarkers for screening precancerous colorectal lesions: a protocol for systematic review and meta-analysis
BMJ Open,
2022
DOI:10.1136/bmjopen-2021-060712
|
|
|
|
|
[6]
|
“Rescue” of Nonparticipants in Colorectal Cancer Screening: A Randomized Controlled Trial of Three Noninvasive Test Options
Cancer Prevention Research,
2021
DOI:10.1158/1940-6207.CAPR-21-0080
|
|
|
|
|
[7]
|
Colorectal cancer screening and diagnosis: omics-based technologies for development of a non-invasive blood-based method
Expert Review of Anticancer Therapy,
2021
DOI:10.1080/14737140.2021.1882858
|
|
|
|
|
[8]
|
Sensitive detection of colorectal cancer in peripheral blood by a novel methylation assay
Clinical Epigenetics,
2021
DOI:10.1186/s13148-021-01076-8
|
|
|
|
|
[9]
|
Colorectal Cancer Screening: Have We Addressed Concerns and Needs of the Target Population?
Gastrointestinal Disorders,
2021
DOI:10.3390/gidisord3040018
|
|
|
|
|
[10]
|
Current Endpoints of Clinical Trials in Ulcerative Colitis: Are They Valid?
Current Treatment Options in Gastroenterology,
2020
DOI:10.1007/s11938-019-00259-w
|
|
|
|
|
[11]
|
Serum SYPL1 is a promising diagnostic biomarker for colorectal cancer
Clinica Chimica Acta,
2020
DOI:10.1016/j.cca.2020.05.048
|
|
|
|
|
[12]
|
Cell-free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review
Journal of Surgical Research,
2019
DOI:10.1016/j.jss.2018.11.029
|
|
|
|
|
[13]
|
Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer—a clinical biomarker discovery and validation study
Clinical Epigenetics,
2019
DOI:10.1186/s13148-019-0757-3
|
|
|
|
|
[14]
|
DNA Methylation Cancer Biomarkers: Translation to the Clinic
Frontiers in Genetics,
2019
DOI:10.3389/fgene.2019.01150
|
|
|
|
|
[15]
|
Circulating Extracellular Vesicle MicroRNA as Diagnostic Biomarkers in Early Colorectal Cancer—A Review
Cancers,
2019
DOI:10.3390/cancers12010052
|
|
|
|
|
[16]
|
A Randomized Controlled Trial Testing Provision of Fecal and Blood Test Options on Participation for Colorectal Cancer Screening
Cancer Prevention Research,
2019
DOI:10.1158/1940-6207.CAPR-19-0089
|
|
|
|
|
[17]
|
Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?
BMC Public Health,
2018
DOI:10.1186/s12889-017-4634-8
|
|
|
|
|
[18]
|
The Influence of Social Conditions Across the Life Course on the Human Gut Microbiota: A Pilot Project With the Wisconsin Longitudinal Study
The Journals of Gerontology: Series B,
2017
DOI:10.1093/geronb/gbx029
|
|
|
|
|
[19]
|
A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia
Clinical and Translational Gastroenterology,
2016
DOI:10.1038/ctg.2015.67
|
|
|
|
|
[20]
|
Exosomal microRNA Biomarkers: Emerging Frontiers in Colorectal and Other Human Cancers
Expert Review of Molecular Diagnostics,
2016
DOI:10.1586/14737159.2016.1156535
|
|
|
|
|
[21]
|
Improving Participation in Colorectal Cancer Screening: a Randomised Controlled Trial of Sequential Offers of Faecal then Blood Based Non-Invasive Tests
Asian Pacific Journal of Cancer Prevention,
2016
DOI:10.7314/APJCP.2015.16.18.8455
|
|
|
|
|
[22]
|
Evaluation of a 5-Marker Blood Test for Colorectal Cancer Early Detection in a Colorectal Cancer Screening Setting
Clinical Cancer Research,
2016
DOI:10.1158/1078-0432.CCR-15-1268
|
|
|
|
|
[23]
|
Blood‐based screening for bowel cancer may not resolve suboptimal screening participation in Australia
Australian and New Zealand Journal of Public Health,
2016
DOI:10.1111/1753-6405.12523
|
|
|
|
|
[24]
|
Blood‐based screening for bowel cancer may not resolve suboptimal screening participation in Australia
Australian and New Zealand Journal of Public Health,
2016
DOI:10.1111/1753-6405.12523
|
|
|
|
|
[25]
|
Rising incidence of early‐onset colorectal cancer in Australia over two decades: Report and review
Journal of Gastroenterology and Hepatology,
2015
DOI:10.1111/jgh.12792
|
|
|
|
|
[26]
|
A Two-Gene Blood Test for Methylated DNA Sensitive for Colorectal Cancer
PLOS ONE,
2015
DOI:10.1371/journal.pone.0125041
|
|
|
|
|
[27]
|
Blood-Based Protein Biomarker Panel for the Detection of Colorectal Cancer
PLOS ONE,
2015
DOI:10.1371/journal.pone.0120425
|
|
|
|
|
[28]
|
Rising incidence of early-onset colorectal cancer in Australia over two decades: Report and review
Journal of Gastroenterology and Hepatology,
2015
DOI:10.1111/jgh.12792
|
|
|
|
|
[29]
|
Blood Tests for Colorectal Cancer Screening in the Standard Risk Population
Current Colorectal Cancer Reports,
2015
DOI:10.1007/s11888-015-0293-2
|
|
|
|
|
[30]
|
Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia
BMC Cancer,
2015
DOI:10.1186/s12885-015-1674-2
|
|
|
|
|
[31]
|
Colorectal cancer biomarker discovery and validation using LC-MS/MS-based proteomics in blood: truth or dare?
Expert Review of Proteomics,
2014
DOI:10.1586/14789450.2014.905743
|
|
|
|